Market Outlook
The global DPT Vaccines market size was valued at USD 5338.1 million in 2022 and is forecast to a readjusted size of USD 6722.7 million by 2029 with a CAGR of 3.3% during review period.
The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc. The top 2 companies hold a share over 90%. Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
This report is a detailed and comprehensive analysis for global DPT Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Age. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global DPT Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2018-2029
Global DPT Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2018-2029
Global DPT Vaccines market size and forecasts, by Type and by Age, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2018-2029
Global DPT Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for DPT Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global DPT Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segmentation By Type
DTaP
Tdap
DTwP
12 Months Below
12 Months Above
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the DPT vaccines market in 2025?
The DPT vaccines market benefits from strong government support and immunization programs globally. This results in high vaccination coverage and growing public awareness of the importance of immunization. The ongoing advancements in vaccine technology also help improve the efficacy and safety profiles of DPT vaccines, making them more trusted by healthcare providers and patients.
What weaknesses might affect the DPT vaccines market in 2025?
One challenge could be the potential for vaccine hesitancy, driven by misinformation or fears about vaccine safety, which can impact immunization rates. Additionally, the cost of producing and distributing vaccines, especially in low-income countries, might limit their availability and access.
What opportunities exist for the DPT vaccines market in 2025?
There is significant opportunity in expanding vaccination programs in emerging markets where immunization coverage is still low. Additionally, advancements in combination vaccines (like DTP-HepB-Hib) offer the chance to streamline vaccine schedules, increasing efficiency in immunization campaigns. Collaborative global initiatives could also enhance market growth.
What threats could hinder the growth of the DPT vaccines market in 2025?
Economic downturns or political instability in certain regions might reduce vaccine funding or availability. Moreover, the emergence of new infectious diseases or competing vaccine options could shift attention away from DPT vaccines, creating market disruption. Lastly, regulatory hurdles or changes in vaccine approval processes could delay the introduction of new formulations.
Market PESTEL Analysis
What political factors influence the DPT vaccines market in 2025?
Government policies and international agreements around public health initiatives significantly impact the DPT vaccines market. Increased funding for immunization programs and global partnerships such as GAVI (Global Alliance for Vaccines and Immunization) play a crucial role in vaccine distribution, particularly in low-income regions.
How do economic factors affect the DPT vaccines market in 2025?
Economic conditions directly influence vaccine affordability and accessibility. Economic downturns can strain healthcare budgets, impacting the availability of vaccines in underfunded regions. Conversely, growing economies may lead to increased healthcare investments and better vaccination programs.
What social factors are relevant to the DPT vaccines market in 2025?
Public awareness and cultural attitudes toward vaccination are key social factors. A greater focus on health education and the benefits of immunization can encourage higher vaccination rates. However, vaccine hesitancy driven by misinformation and societal misconceptions can slow down progress in some regions.
How do technological factors impact the DPT vaccines market in 2025?
Advancements in vaccine production technologies, such as more efficient manufacturing methods and the development of combination vaccines, improve both vaccine supply and effectiveness. Innovations in cold chain logistics and digital tracking systems also enhance the distribution and monitoring of DPT vaccines.
What environmental factors affect the DPT vaccines market in 2025?
Environmental sustainability is becoming increasingly important in the vaccine industry, with a focus on reducing the carbon footprint of production and distribution processes. Additionally, climate change and natural disasters can disrupt vaccine supply chains, especially in vulnerable regions, making access more challenging.
What legal factors influence the DPT vaccines market in 2025?
Strict regulations on vaccine safety, efficacy, and approval processes impact the DPT vaccines market. Legal requirements for vaccine trials, safety standards, and post-market surveillance are crucial in ensuring the quality and reliability of vaccines. In some regions, legal mandates for vaccination can also boost market demand.
Market SIPOC Analysis
Who are the suppliers in the DPT vaccines market in 2025?
The suppliers include pharmaceutical manufacturers, raw material providers (such as antigens, preservatives, and adjuvants), and cold chain logistics companies that ensure proper vaccine storage and transportation. Government health organizations and international bodies like WHO and GAVI also play a role in facilitating vaccine procurement and distribution.
What are the inputs required in the DPT vaccines market in 2025?
The primary inputs include the ingredients for vaccine production, such as bacteria or toxins, adjuvants, and stabilizers. Manufacturing technology and equipment for vaccine production, as well as regulatory approvals and guidelines, are essential to ensure quality and safety. Training and skilled labor are also vital inputs to the market.
What processes are involved in the DPT vaccines market in 2025?
Key processes in the market include vaccine research and development, manufacturing, quality control, and regulatory approval. Distribution processes involve cold chain management, logistics, and delivery to healthcare providers, who administer the vaccines in public health programs or clinics. Continuous monitoring and reporting are necessary for ensuring safety and efficacy.
Who are the customers in the DPT vaccines market in 2025?
The customers include government health agencies, international organizations, hospitals, clinics, and healthcare providers who directly administer vaccines. The end customers are individuals, especially infants and young children, receiving the vaccines as part of national immunization programs to protect against diphtheria, pertussis, and tetanus.
What are the outputs in the DPT vaccines market in 2025?
The outputs are the DPT vaccines themselves, ready for distribution and administration. These vaccines help prevent serious diseases like diphtheria, pertussis, and tetanus. Alongside the vaccines, output includes data on immunization rates and public health outcomes, contributing to better healthcare planning and policy-making.
Market Porter's Five Forces
What is the threat of new entrants in the DPT vaccines market in 2025?
The threat of new entrants is relatively low due to high barriers to entry. Vaccine development requires significant capital investment, regulatory approvals, and expertise in biotechnology and immunology. Additionally, established players already dominate the market, making it challenging for new companies to break in.
How strong is the bargaining power of suppliers in the DPT vaccines market in 2025?
The bargaining power of suppliers is moderate. While there are specialized suppliers for vaccine ingredients and raw materials, the overall supply chain is well-established, and large vaccine manufacturers have the scale to negotiate favorable terms. However, the need for high-quality ingredients and compliance with strict regulations gives some leverage to suppliers.
What is the bargaining power of buyers in the DPT vaccines market in 2025?
The bargaining power of buyers is relatively low, as most buyers are government organizations and international health agencies that prioritize public health initiatives. These buyers tend to work with a limited number of vaccine manufacturers and are often bound by regulatory agreements, giving them less influence on price or terms compared to other markets.
How high is the threat of substitute products in the DPT vaccines market in 2025?
The threat of substitutes is low. DPT vaccines are essential for immunization against three deadly diseases—diphtheria, pertussis, and tetanus—making them irreplaceable. While there are combination vaccines that can include DPT along with other vaccines, there are few viable substitutes for the specific protection these vaccines offer.
What is the intensity of competitive rivalry in the DPT vaccines market in 2025?
The intensity of competitive rivalry is moderate. The market is dominated by a few large, well-established vaccine manufacturers with strong brand recognition and extensive distribution networks. However, competition still exists between these players to maintain market share and expand to emerging markets, driving innovation and improvements in vaccine offerings.
Market Upstream Analysis
What are the key raw materials required in the DPT vaccines market in 2025?
The key raw materials include antigens derived from bacteria or their toxins, stabilizers, preservatives, and adjuvants to enhance immune responses. Additionally, specialized equipment and technology for the formulation and manufacturing process are crucial.
What role do suppliers play in the DPT vaccines market in 2025?
Suppliers provide the essential components for vaccine production, such as raw materials (e.g., diphtheria, pertussis, and tetanus antigens), as well as packaging materials and cold storage solutions. They ensure that manufacturers have consistent access to high-quality inputs required for production.
How does research and development impact the upstream processes in the DPT vaccines market in 2025?
R&D is vital for improving vaccine efficacy, safety, and manufacturing processes. Innovations in vaccine formulations, including combination vaccines and improvements in adjuvants, influence upstream activities, driving demand for new raw materials and technologies. Continuous research also ensures that vaccines meet regulatory requirements.
What are the regulatory challenges faced by upstream players in the DPT vaccines market in 2025?
Regulatory hurdles are significant for upstream players as they must comply with strict health standards, safety protocols, and approval processes set by authorities like the FDA and WHO. Ensuring the quality and safety of raw materials and finished products requires constant monitoring and adherence to evolving regulations.
How do economic factors influence upstream activities in the DPT vaccines market in 2025?
Economic conditions can affect the cost of raw materials, manufacturing processes, and technology development. For instance, inflation or supply chain disruptions might increase the costs of producing vaccines, impacting the availability and pricing of DPT vaccines. Conversely, economic growth can lead to more funding for research and development, boosting upstream activities.
Market Midstream Analysis
What are the key activities involved in the midstream segment of the DPT vaccines market in 2025?
The key activities in the midstream segment include vaccine manufacturing, quality control, packaging, and preparation for distribution. This stage involves large-scale production, adherence to stringent regulatory standards, and ensuring the vaccine is ready for shipping under appropriate conditions.
How does logistics impact the midstream processes in the DPT vaccines market in 2025?
Logistics plays a critical role in ensuring that DPT vaccines are stored and transported under optimal conditions, especially in maintaining the cold chain. Efficient transportation and distribution networks are crucial for timely delivery to healthcare facilities, especially in remote or underserved regions.
What are the challenges faced in the midstream processes of the DPT vaccines market in 2025?
One challenge is managing the cold chain effectively, as DPT vaccines require strict temperature control during transport and storage. Delays or disruptions in the supply chain can affect vaccine potency. Additionally, manufacturing delays or quality control issues can cause shortages or gaps in availability.
How do technological advancements impact the midstream segment of the DPT vaccines market in 2025?
Technological advancements, such as improved vaccine production technologies and better cold chain management systems, enhance the efficiency and reliability of the midstream processes. Automation in manufacturing and advanced tracking systems for logistics also improve accuracy and reduce operational risks.
What role do partnerships and collaborations play in the midstream activities of the DPT vaccines market in 2025?
Partnerships between vaccine manufacturers, logistics providers, and government agencies are essential for streamlining the midstream processes. These collaborations ensure that vaccines are produced on time, distributed efficiently, and made available to the populations that need them, especially in underserved areas.
Market Downstream Analysis
What are the key activities in the downstream segment of the DPT vaccines market in 2025?
The key activities in the downstream segment include vaccine distribution to healthcare providers, administration of vaccines to the target population (primarily children), and post-vaccination monitoring for safety and efficacy. This stage also involves public health campaigns to promote vaccine uptake.
How do healthcare providers impact the downstream processes in the DPT vaccines market in 2025?
Healthcare providers are essential in administering DPT vaccines, educating patients and caregivers about the benefits, and monitoring for any adverse effects. They play a critical role in ensuring vaccination rates are high and that the vaccines are administered according to recommended schedules.
What are the challenges faced in the downstream segment of the DPT vaccines market in 2025?
Challenges include vaccine hesitancy due to misinformation or cultural beliefs, which can lead to lower vaccination rates. Additionally, logistical issues, such as vaccine wastage or delays in distribution, can result in gaps in coverage, particularly in remote or underserved regions.
How do government policies influence the downstream processes of the DPT vaccines market in 2025?
Government policies significantly influence vaccine distribution and administration by setting vaccination schedules, funding public health campaigns, and mandating vaccination for school enrollment. Effective policies ensure that vaccines reach the appropriate populations, especially in areas with lower access to healthcare.
What role do awareness and education play in the downstream segment of the DPT vaccines market in 2025?
Awareness and education are crucial for improving vaccine acceptance and participation in immunization programs. Public health campaigns, often led by governments or international organizations, help to counteract vaccine misinformation and emphasize the importance of DPT vaccination in preventing deadly diseases.
Chapter 1, to describe DPT Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of DPT Vaccines, with price, sales, revenue and global market share of DPT Vaccines from 2018 to 2023.
Chapter 3, the DPT Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DPT Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and age, with sales market share and growth rate by type, age, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and DPT Vaccines market forecast, by regions, type and age, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of DPT Vaccines.
Chapter 14 and 15, to describe DPT Vaccines sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of DPT Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global DPT Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 DTaP
1.3.3 Tdap
1.3.4 DTwP
1.4 Market Analysis by Age
1.4.1 Overview: Global DPT Vaccines Consumption Value by Age: 2018 Versus 2022 Versus 2029
1.4.2 12 Months Below
1.4.3 12 Months Above
1.5 Global DPT Vaccines Market Size & Forecast
1.5.1 Global DPT Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global DPT Vaccines Sales Quantity (2018-2029)
1.5.3 Global DPT Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur DPT Vaccines Product and Services
2.1.4 Sanofi Pasteur DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK DPT Vaccines Product and Services
2.2.4 GSK DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Mitsubishi Tanabe Pharma
2.3.1 Mitsubishi Tanabe Pharma Details
2.3.2 Mitsubishi Tanabe Pharma Major Business
2.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Product and Services
2.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.4 KM Biologics
2.4.1 KM Biologics Details
2.4.2 KM Biologics Major Business
2.4.3 KM Biologics DPT Vaccines Product and Services
2.4.4 KM Biologics DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 KM Biologics Recent Developments/Updates
2.5 Wuhan Institute of Biological Products
2.5.1 Wuhan Institute of Biological Products Details
2.5.2 Wuhan Institute of Biological Products Major Business
2.5.3 Wuhan Institute of Biological Products DPT Vaccines Product and Services
2.5.4 Wuhan Institute of Biological Products DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
2.6 Walvax Biotechnology
2.6.1 Walvax Biotechnology Details
2.6.2 Walvax Biotechnology Major Business
2.6.3 Walvax Biotechnology DPT Vaccines Product and Services
2.6.4 Walvax Biotechnology DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Walvax Biotechnology Recent Developments/Updates
2.7 Chengdu Institute of Biological Products
2.7.1 Chengdu Institute of Biological Products Details
2.7.2 Chengdu Institute of Biological Products Major Business
2.7.3 Chengdu Institute of Biological Products DPT Vaccines Product and Services
2.7.4 Chengdu Institute of Biological Products DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
2.8 Minhai Biotechnology
2.8.1 Minhai Biotechnology Details
2.8.2 Minhai Biotechnology Major Business
2.8.3 Minhai Biotechnology DPT Vaccines Product and Services
2.8.4 Minhai Biotechnology DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Minhai Biotechnology Recent Developments/Updates
3 Competitive Environment: DPT Vaccines by Manufacturer
3.1 Global DPT Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global DPT Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global DPT Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of DPT Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 DPT Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 DPT Vaccines Manufacturer Market Share in 2022
3.5 DPT Vaccines Market: Overall Company Footprint Analysis
3.5.1 DPT Vaccines Market: Region Footprint
3.5.2 DPT Vaccines Market: Company Product Type Footprint
3.5.3 DPT Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global DPT Vaccines Market Size by Region
4.1.1 Global DPT Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global DPT Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global DPT Vaccines Average Price by Region (2018-2029)
4.2 North America DPT Vaccines Consumption Value (2018-2029)
4.3 Europe DPT Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific DPT Vaccines Consumption Value (2018-2029)
4.5 South America DPT Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa DPT Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global DPT Vaccines Sales Quantity by Type (2018-2029)
5.2 Global DPT Vaccines Consumption Value by Type (2018-2029)
5.3 Global DPT Vaccines Average Price by Type (2018-2029)
6 Market Segment by Age
6.1 Global DPT Vaccines Sales Quantity by Age (2018-2029)
6.2 Global DPT Vaccines Consumption Value by Age (2018-2029)
6.3 Global DPT Vaccines Average Price by Age (2018-2029)
7 North America
7.1 North America DPT Vaccines Sales Quantity by Type (2018-2029)
7.2 North America DPT Vaccines Sales Quantity by Age (2018-2029)
7.3 North America DPT Vaccines Market Size by Country
7.3.1 North America DPT Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America DPT Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe DPT Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe DPT Vaccines Sales Quantity by Age (2018-2029)
8.3 Europe DPT Vaccines Market Size by Country
8.3.1 Europe DPT Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe DPT Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific DPT Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific DPT Vaccines Sales Quantity by Age (2018-2029)
9.3 Asia-Pacific DPT Vaccines Market Size by Region
9.3.1 Asia-Pacific DPT Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific DPT Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America DPT Vaccines Sales Quantity by Type (2018-2029)
10.2 South America DPT Vaccines Sales Quantity by Age (2018-2029)
10.3 South America DPT Vaccines Market Size by Country
10.3.1 South America DPT Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America DPT Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa DPT Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa DPT Vaccines Sales Quantity by Age (2018-2029)
11.3 Middle East & Africa DPT Vaccines Market Size by Country
11.3.1 Middle East & Africa DPT Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa DPT Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 DPT Vaccines Market Drivers
12.2 DPT Vaccines Market Restraints
12.3 DPT Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of DPT Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of DPT Vaccines
13.3 DPT Vaccines Production Process
13.4 DPT Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 DPT Vaccines Typical Distributors
14.3 DPT Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global DPT Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global DPT Vaccines Consumption Value by Age, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur DPT Vaccines Product and Services
Table 6. Sanofi Pasteur DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK DPT Vaccines Product and Services
Table 11. GSK DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Mitsubishi Tanabe Pharma Major Business
Table 15. Mitsubishi Tanabe Pharma DPT Vaccines Product and Services
Table 16. Mitsubishi Tanabe Pharma DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 18. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 19. KM Biologics Major Business
Table 20. KM Biologics DPT Vaccines Product and Services
Table 21. KM Biologics DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. KM Biologics Recent Developments/Updates
Table 23. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 24. Wuhan Institute of Biological Products Major Business
Table 25. Wuhan Institute of Biological Products DPT Vaccines Product and Services
Table 26. Wuhan Institute of Biological Products DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Wuhan Institute of Biological Products Recent Developments/Updates
Table 28. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 29. Walvax Biotechnology Major Business
Table 30. Walvax Biotechnology DPT Vaccines Product and Services
Table 31. Walvax Biotechnology DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Walvax Biotechnology Recent Developments/Updates
Table 33. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 34. Chengdu Institute of Biological Products Major Business
Table 35. Chengdu Institute of Biological Products DPT Vaccines Product and Services
Table 36. Chengdu Institute of Biological Products DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Chengdu Institute of Biological Products Recent Developments/Updates
Table 38. Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 39. Minhai Biotechnology Major Business
Table 40. Minhai Biotechnology DPT Vaccines Product and Services
Table 41. Minhai Biotechnology DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Minhai Biotechnology Recent Developments/Updates
Table 43. Global DPT Vaccines Sales Quantity by Manufacturer (2018-2023) & (M Doses)
Table 44. Global DPT Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global DPT Vaccines Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 46. Market Position of Manufacturers in DPT Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and DPT Vaccines Production Site of Key Manufacturer
Table 48. DPT Vaccines Market: Company Product Type Footprint
Table 49. DPT Vaccines Market: Company Product Application Footprint
Table 50. DPT Vaccines New Market Entrants and Barriers to Market Entry
Table 51. DPT Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global DPT Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 53. Global DPT Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 54. Global DPT Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global DPT Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global DPT Vaccines Average Price by Region (2018-2023) & (US$/Dose)
Table 57. Global DPT Vaccines Average Price by Region (2024-2029) & (US$/Dose)
Table 58. Global DPT Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 59. Global DPT Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 60. Global DPT Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global DPT Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global DPT Vaccines Average Price by Type (2018-2023) & (US$/Dose)
Table 63. Global DPT Vaccines Average Price by Type (2024-2029) & (US$/Dose)
Table 64. Global DPT Vaccines Sales Quantity by Age (2018-2023) & (M Doses)
Table 65. Global DPT Vaccines Sales Quantity by Age (2024-2029) & (M Doses)
Table 66. Global DPT Vaccines Consumption Value by Age (2018-2023) & (USD Million)
Table 67. Global DPT Vaccines Consumption Value by Age (2024-2029) & (USD Million)
Table 68. Global DPT Vaccines Average Price by Age (2018-2023) & (US$/Dose)
Table 69. Global DPT Vaccines Average Price by Age (2024-2029) & (US$/Dose)
Table 70. North America DPT Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 71. North America DPT Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 72. North America DPT Vaccines Sales Quantity by Age (2018-2023) & (M Doses)
Table 73. North America DPT Vaccines Sales Quantity by Age (2024-2029) & (M Doses)
Table 74. North America DPT Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 75. North America DPT Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 76. North America DPT Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America DPT Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe DPT Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 79. Europe DPT Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 80. Europe DPT Vaccines Sales Quantity by Age (2018-2023) & (M Doses)
Table 81. Europe DPT Vaccines Sales Quantity by Age (2024-2029) & (M Doses)
Table 82. Europe DPT Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 83. Europe DPT Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 84. Europe DPT Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe DPT Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific DPT Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 87. Asia-Pacific DPT Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 88. Asia-Pacific DPT Vaccines Sales Quantity by Age (2018-2023) & (M Doses)
Table 89. Asia-Pacific DPT Vaccines Sales Quantity by Age (2024-2029) & (M Doses)
Table 90. Asia-Pacific DPT Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 91. Asia-Pacific DPT Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 92. Asia-Pacific DPT Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific DPT Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America DPT Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 95. South America DPT Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 96. South America DPT Vaccines Sales Quantity by Age (2018-2023) & (M Doses)
Table 97. South America DPT Vaccines Sales Quantity by Age (2024-2029) & (M Doses)
Table 98. South America DPT Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 99. South America DPT Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 100. South America DPT Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America DPT Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa DPT Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 103. Middle East & Africa DPT Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 104. Middle East & Africa DPT Vaccines Sales Quantity by Age (2018-2023) & (M Doses)
Table 105. Middle East & Africa DPT Vaccines Sales Quantity by Age (2024-2029) & (M Doses)
Table 106. Middle East & Africa DPT Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 107. Middle East & Africa DPT Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 108. Middle East & Africa DPT Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa DPT Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 110. DPT Vaccines Raw Material
Table 111. Key Manufacturers of DPT Vaccines Raw Materials
Table 112. DPT Vaccines Typical Distributors
Table 113. DPT Vaccines Typical Customers
List of Figures
Figure 1. DPT Vaccines Picture
Figure 2. Global DPT Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global DPT Vaccines Consumption Value Market Share by Type in 2022
Figure 4. DTaP Examples
Figure 5. Tdap Examples
Figure 6. DTwP Examples
Figure 7. Global DPT Vaccines Consumption Value by Age, (USD Million), 2018 & 2022 & 2029
Figure 8. Global DPT Vaccines Consumption Value Market Share by Age in 2022
Figure 9. 12 Months Below Examples
Figure 10. 12 Months Above Examples
Figure 11. Global DPT Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global DPT Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global DPT Vaccines Sales Quantity (2018-2029) & (M Doses)
Figure 14. Global DPT Vaccines Average Price (2018-2029) & (US$/Dose)
Figure 15. Global DPT Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global DPT Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of DPT Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 DPT Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 DPT Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global DPT Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global DPT Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 22. North America DPT Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe DPT Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific DPT Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. South America DPT Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa DPT Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 27. Global DPT Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global DPT Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 29. Global DPT Vaccines Average Price by Type (2018-2029) & (US$/Dose)
Figure 30. Global DPT Vaccines Sales Quantity Market Share by Age (2018-2029)
Figure 31. Global DPT Vaccines Consumption Value Market Share by Age (2018-2029)
Figure 32. Global DPT Vaccines Average Price by Age (2018-2029) & (US$/Dose)
Figure 33. North America DPT Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America DPT Vaccines Sales Quantity Market Share by Age (2018-2029)
Figure 35. North America DPT Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America DPT Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 37. United States DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe DPT Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe DPT Vaccines Sales Quantity Market Share by Age (2018-2029)
Figure 42. Europe DPT Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe DPT Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific DPT Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific DPT Vaccines Sales Quantity Market Share by Age (2018-2029)
Figure 51. Asia-Pacific DPT Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific DPT Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 53. China DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America DPT Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America DPT Vaccines Sales Quantity Market Share by Age (2018-2029)
Figure 61. South America DPT Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America DPT Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa DPT Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa DPT Vaccines Sales Quantity Market Share by Age (2018-2029)
Figure 67. Middle East & Africa DPT Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa DPT Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. DPT Vaccines Market Drivers
Figure 74. DPT Vaccines Market Restraints
Figure 75. DPT Vaccines Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of DPT Vaccines in 2022
Figure 78. Manufacturing Process Analysis of DPT Vaccines
Figure 79. DPT Vaccines Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
